» Articles » PMID: 36532075

Phosphorylation of RIPK1 Serine 25 Mediates IKK Dependent Control of Extrinsic Cell Death in T Cells

Overview
Journal Front Immunol
Date 2022 Dec 19
PMID 36532075
Authors
Affiliations
Soon will be listed here.
Abstract

The Inhibitor of Kappa B Kinase (IKK) complex is a critical regulator of NF-κB activation. More recently, IKK has also been shown to repress RIPK1 dependent extrinsic cell death pathways by directly phosphorylating RIPK1 at serine 25. In T cells, IKK expression is essential for normal development in the thymus, by promoting survival of thymocytes independently of NF-κB activation. RIPK1 undergoes extensive phosphorylation following TNF stimulation in T cells, though which targets are required to repress RIPK1 has not been defined. Here, we show that TNF induced phosphorylation of RIPK1 at S25 is IKK dependent. We test the relevance of this phosphorylation event in T cells using mice with a RIPK1 phosphomimetic point mutation to endogenous RIPK1. We find that this mutation protects T cells from TNF induced cell death when IKK activity is inhibited , and can rescues development of IKK deficient thymocytes to a degree comparable with kinase dead RIPK1. Together, these data show that phosphorylation of RIPK1S25 by IKK represents a key regulatory event promoting survival of T cells by IKK.

Citing Articles

NF-κB regulated expression of A20 controls IKK dependent repression of RIPK1 induced cell death in activated T cells.

Layzell S, Barbarulo A, van Loo G, Beyaert R, Seddon B Cell Death Differ. 2024; 32(2):256-270.

PMID: 39327505 PMC: 11802744. DOI: 10.1038/s41418-024-01383-6.


Activation of the NLRP1B inflammasome by caspase-8.

Meade J, Stuart S, Neiman-Zenevich J, Krustev C, Girardin S, Mogridge J Commun Biol. 2024; 7(1):1164.

PMID: 39289441 PMC: 11408587. DOI: 10.1038/s42003-024-06882-3.


Targeting necroptosis: a promising avenue for respiratory disease treatment.

Cao X, Tan J, Zheng R, Wang F, Zhou L, Yi J Cell Commun Signal. 2024; 22(1):418.

PMID: 39192326 PMC: 11350980. DOI: 10.1186/s12964-024-01804-6.


A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death.

Mannion J, Gifford V, Bellenie B, Fernando W, Garcia L, Wilson R Immunity. 2024; 57(7):1514-1532.e15.

PMID: 38788712 PMC: 11236506. DOI: 10.1016/j.immuni.2024.04.025.


A guide to cell death pathways.

Yuan J, Ofengeim D Nat Rev Mol Cell Biol. 2023; 25(5):379-395.

PMID: 38110635 DOI: 10.1038/s41580-023-00689-6.


References
1.
Webb L, Ley S, Seddon B . TNF activation of NF-κB is essential for development of single-positive thymocytes. J Exp Med. 2016; 213(8):1399-407. PMC: 4986527. DOI: 10.1084/jem.20151604. View

2.
Dondelinger Y, Delanghe T, Rojas-Rivera D, Priem D, Delvaeye T, Bruggeman I . MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nat Cell Biol. 2017; 19(10):1237-1247. DOI: 10.1038/ncb3608. View

3.
de Boer J, Williams A, Skavdis G, Harker N, Coles M, Tolaini M . Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol. 2003; 33(2):314-25. DOI: 10.1002/immu.200310005. View

4.
Bonizzi G, Karin M . The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004; 25(6):280-8. DOI: 10.1016/j.it.2004.03.008. View

5.
Wan Y, Chi H, Xie M, Schneider M, Flavell R . The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat Immunol. 2006; 7(8):851-8. DOI: 10.1038/ni1355. View